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In two estrogen-sensitive cell lines, Le42 and MCF-7, the estrogenic potential of the nonsteroidal mycotoxin zearalenone 
has been investigated. The chloramphenicol acetyltransferase (CAT) gene expression in Le42 cells is induced by zearale- 
none after transfection with a CAT-gene construct controlled by an estrogen responsive element [(1986) Cell 46, 1053- 
10611. In MCF-7 cells zearalenone induces at least 2 exoproteins (52 and 160 kDa) which are estrogen-specific [(1980) 
Cell 20, 3533362). These data suggest that zearalenone acts by activating the estrogen receptor. Due to the high sensitivity 
of these cell lines for zearalenone both test systems are proposed as assays for a quantitative estimation of the biological 
(estrogenic) activity of this widespread mycotoxin. 
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1. INTRODUCTION 
The mycotoxin zearalenone is produced by 
several Fusarium species and is one of the fre- 
quently occurring contaminants in cereals and 
other plant products (3s. It. e%xhibits e t.rogenic &- 
fects and presenlf a pr&em mainly to agriculture 
by causing diseases of the reproductive system, im- 
paired fertility, and abnormal fetal development in 
farm animals [3]. A health risk to man has to be 
cons&& a% =n&l. 5??~~5usrJ y&et-,-La< ~GGI~B <n 
children reported in Puerto Rico [4], and the high 
incidence of esophageal cancer jn ASrjca and 
China seem to be due to zeara’rertane iwestion 
J3,41. 
Although its chemical structure is nonsteroidal, 
zearalenone binds to the estrogen receptor (ER), 
but with relative low affinity (2-5% of 17,& 
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estradiol) [5-7J. Several estrogenic effects on 
molecular level, such as alterations of various hor- 
mone concentrations [a], eIevation of serum 
triglyceride levels [9], increased activity of uterine 
acetylcholine esterase [lo] and uterine creatine 
kinase { 5 J &We been r,ZpGr&d . This paper describes 
the responses of Two ER-pro&~& ccl) lines, 
MCF-7 [2] and Le42 [l 11, to zearalenone. Direct 
evidence is presented that the ER is activated by 
estrogen and zearalenone basically in the same 
WV, ~lX!l+l~ +& QlX +&&&w& Vf %?%i%W~~ 
controlled gene products. Furthermore it is shown 
that estimations of &se gene p106UcYs can seTue as 
hi$nYr~ sen&ive kk~assays ‘ior a qua~~i~a~ive b&5+- 
mination of the estrogenic potential of 
zearalenone. Avoiding animal experiments, these 
systems present easy to handle alternatives to the in 
vivo uterotropic assay performed in rodents [12] 
which is presently used as the official bioassay for 
this mycotoxin. 
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forschungszentrum Karlsruhe, FRG. Both cell lines were main- 
tained as described [2,11]. 3 days prior to experiments fetal calf 
serum was replaced by serum treated with dextran coated char- 
coal (MCF-7 cells) [2] or with Ultroser SF, Serva (Le42 cells) 
[ill. 
2.2. Transfection of Le42 cells and CAT assay 
The recombinant plasmids pA2( - 33 l/- 87)tk-CAT, con- 
taining an ERE, and pA2( - 260/- 87)tkCAT, without ERE, 
were provided by Dr G. Ryffel, Karlsruhe, and are described in 
detail in [l]. Transfections into Le42 cells were performed using 
the calcium phosphate precipitation technique according to 
[13]. 10 pg DNA was used per 10 cm petri dish containing 5 x 
lo5 cells. After transfection cells were stimulated for 72 h and 
CAT activity in the lysates was estimated according to [13]. 
2.3. Stimulation of MCF-7 cells and analysis of exoproteins 
Stimulation of MCF-7 cells and in vivo labeling with 
[?S]methionine were done in microtiter plates (0.8 cm diameter 
per well) following the protocol described in [2]. Treatment 
with estradiol and zearalenone continued for 48 or 72 h. Ex- 
oproteins were analyzed by SDS-polyacrylamide gel elec- 
trophoresis of 25 pl of the medium [15] and subsequent 
fluorography using Amplify TM (Amersham). 
2.4. Inactivation and estimation of zearalenone 
Zearalenone was inactivated by autoclaving with 2% ae- 
queous ammonia for 30 h. Zearalenone concentration was 
estimated by high-performance liquid chromatography using a 
10 pm Porasil column (Waters), with dichloromethane/acetic 
acid/ethanol (98: 1: 1) as the liquid phase, and fluorescence 
detection (excitation wavelength, 280 nm; emission wavelength, 
465 nm) [16]. 
3. RESULTS 
To investigate whether the zearalenone/ER 
complex exhibits the same functional properties as 
the genuine estrogen/ER complex, a system was 
used which was developed by Klein-Hitpal et al. 
[l] and Druege et al. [ll]. 
This system is composed of ER-producing target 
cells (Le42) [l I] and the recombinant plasmid 
pA2( - 33 l/ - 87)tk-CAT [ 1,l l] which is transfect- 
ed into these cells. Le42 cells are derived from 
mouse Ltk- cells and contain the stable transfected 
gene of the human ER whose expression is directed 
by the SV40 ‘early’ promotor [ 111. The plasmid us- 
ed is a derivative of pSVO-CAT [14] containing an 
ERE from Xenopus laevis and bases - 150 to + 51 
of the thymidine kinase promotor of Herpes 
simplex virus [l]. The CAT gene is transiently ex- 
pressed after transfection of the plasmid into Le42 
cells and subsequent treatment with estradiol [l I]. 
Fig. 1 shows the CAT activities after treatment with 
different concentrations of 17P-estradiol (fig. la) 
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Fig.1. CAT activity in the lysates of 2.5 x IO5 transfected Le42 
cells after treatment with different concentrations of 17fl- 
estradiol (a), zearalenone (b) and ammonia inactivated 
zearalenone (c). The control (0) represents untreated cells. 
Concentrations are indicated in molarity (M). The 
autoradiography of a thin layer chromatogram is shown in 
which the substrate ([‘4C]chloramphenicol, lower spots) is 
separated from the acetylated forms (the upper spots 
correspond to 3-acetate chloramphenicol). 
and zearalenone (fig.lb). The threshold of induc- 
tion lies between 2.5 x 10-r’ M and 2.5 x 10m9 M 
with estradiol, while induction with zearalenone 
requires concentrations between 5 x 10e9 M and 
5 X lo-’ M. This result corresponds well with the 
affinity of zearalenone to the human ER which has 
been reported to be 20-fold lower than the affinity 
of 17,6-estradiol [7]. 
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The specificity of the system was investigated by 
zearalenone inactivated by incubation with am- 
monia (section 2). Ammonia treatment of 
zearalenone leads to a reduction of its estrogenic 
potential in vivo [17]. The preparation used here 
contained 5.5% residual, chemically intact, 
zearalenone. CAT induction with this material is 
shown in fig.lc. Half-maximal induction was 
achieved at a concentration of 5 x 10-’ M. 
Therefore, the capacity of this material is between 
10 and lOGfold lower than that of untreated 
zearalenone which fits well to the concentration of 
intact zearalenone (5.5%) estimated in this 
prepav&mc 
In a control experiment Le42 cells were 
transfected with pA2( - 260/ - 87)tk-CAT, a dele- 
tion of pA2( - 331/- 87)tk-CAT which does not 
cont&T ?;nPEX+ 521. Xv >,n.&i&~~ v?c ZZkT xPXQT 
coulcb’-De 6Dserveb after trealmen’l wXn e%Tatil& 0~ 
zearalenone (not shown). 
These results were substantiated in another 
system, the MCF-7 cell line, which reconstitutes an 
estal&shed, estrogen-sensitive ccl line derived 
from human breast cancer [2]. Estrogen treatment 
of these cells leads to the induction of several 
exoproteins; the most prominent is of 52 kDa, 
another of 160 kDa [2]. This effect is highly 
specific, since treatment with other steroid hor- 
mones like progesterone or dexamethasone does 
not lead to the induction of exoprotein synthesis 
r21. 
MCF-7 cells were stimulated with 17@estradiol 
or zearalenone for 3 days. Exoproteins were la- 
beled ‘In $vo +>%-I )“S>rne%-i~orime, separateh 'TTY 
electrophoresis and autoradiographed. Fig.2 
shows the results using lo-” M estradiol (lane 2) 
and zearalenone (lane 3). Induction of a 52 kDa 
and a 160 kDa protein can clearly be detected after 
treatment with both compounds. With both 
estradiol and zearalenone this induction has 
alre&Y ~a&& ‘% l%a<<l%& ‘+e& +% &%w$s * 
the lowest tested concentration (lo-” M), in- 
dicating the high sensitivity of this system. Am- 
monia-treated zearalenone containing 5.5 070 intact 
zearalenone was also tested. Fig.2, lane 4 shows 
the result using 10m9 M of this material. For 
maximal induction the concentration has to be at 
least lOO-fold higher compared with untreated 
zearalenone (not shown). 
Fig.2. Autoradiography of [‘%)methionine labeled exoproteins 
produced by MCF-7 cells after 72 h treatment with lo-” M 
17fi-estradiol (lane 2), lo-” M zearalenone (lane 3), 10m9 M 
ammonia inactivated zearalenone (lane 4) and without 
treatment (lane 1). Proteins were separated by SDS- 
p&2q~)amik gd &chp9xresjs 113 usjng a g+El cont;ijning 
10% acrylamide and 0.27% bisacrylamide. 
estradiol and zearalenone (stimulation was for 
48 h only; not shown) revealed, that 17,&estradiol 
has an efficiency between lo- and lOO-fold higher 
+&%?& “ZKZ&?XQ&, 2 X&J Y&&%!& ;r, I;%X%Qn&aX& 
with the data obtained with transfected Le42 cells. 
4. DISCUSSION 
A comparison of the inducing capacities of 
The induction of estrogen-controlled genes in 
estrogen-sensitive tissue culture cell lines by 
zearalenone supports the idea that this 
nonsteroidal mycotoxin acts as an agonist by ac- 
tivating the estrogen receptor (ER). 
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Steroid hormone-dependent gene regulation is 
not yet understood in full detail. Different models 
are discussed in [18]. Recent findings concerning 
glucocorticoid indicate that the steroid free recep- 
tor together with hsp90 heat shock protein is part 
of a heteromeric complex, from which it is released 
upon addition of the hormone [19]. The steroid 
hormone ligand seems not to be necessary for 
specific binding of the receptor to DNA [20,21]. If 
a similar model holds true for estrogen, the action 
of zearalenone is the dissociation of a complex 
containing the ER and a modulating protein. 
Gene induction with zearalenone in MCF-7 cells 
and transfected Le42 cells requires between lo- and 
lOO-fold higher concentrations as compared with 
17,&estradiol. This is concomitant with the estima- 
tion of the affinity of zearalenone to the human 
ER which in MCF-7 cells has been demonstrated to 
be 5% as compared with 17&estradiol [7]. It 
should be noted that the estrogenic potency of 
zearalenone in living animals, using different 
assays, is between lOO- and lOOO-fold lower than 
that of 17,&estradiol [3,5]. An important feature 
of the described systems is the fact that they should 
be useful tools in zearalenone analysis: they exhibit 
high sensitivity, high specificity, and are easy to 
handle. The most common bioassay for 
zearalenone is the estimation of the uterotropic ef- 
fect in rodents [12], a laborious procedure involv- 
ing numerous animal experiments. A quantitative 
estimation of the biological (estrogenic) effect is 
almost impossible using this method. The systems 
described here combine the possibilities of detect- 
ing the biological activity of zearalenone and its 
quantitative estimation. Other estrogenic active 
compounds are not discriminated, but this may 
even be advantageous, e.g. in assessing the quality 
of foodstuffs. 
The Le42 system can further be improved by the 
isolation of Le42 clones containing the stable 
transfected plasmid pA2( - 331/- 87)tk-CAT. A 
screening for stably transfected cell lines exhibiting 
a higher sensitivity towards estrogens or estrogenic 
active compounds provides an additional in- 
teresting aspect. 
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